Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs SharkNinja Inc. Ordinary Shares (SN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs SharkNinja Inc. Ordinary Shares — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.75 (market cap $8.88B), while SharkNinja Inc. Ordinary Shares trades at $187.41 (market cap $26.25B). The key difference: SharkNinja Inc. Ordinary Shares is far larger — about 3× Kymera Therapeutics Inc. Common Stock's market cap, and SharkNinja Inc. Ordinary Shares is trading nearer its 52-week high, Kymera Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and SharkNinja Inc. Ordinary Shares for 3 Days on average.
| KYMR | SN | |
|---|---|---|
Market Cap | $8.88B | $26.25B |
Volume | 1,028,790 | 1,135,281 |
Sector | Health | Consumer Cyclical |
52-Week High | $127.31 | $192.86 |
52-Week Low | $55.80 | $84.57 |
Typical Hold Time | 0 Days | 3 Days |
Enterprise Value | $8.27B | $26.38B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SharkNinja (SN) trades at $188.80, down 0.62% with a bullish technical outlook supported by moving averages. The company demonstrates strong fundamentals with consistent earnings beats, 10.06% net margin, and robust cash flow growth. Recent product launches including new vacuum and kitchen systems highlight ongoing innovation. Analyst sentiment remains overwhelmingly positive with 91% buy ratings and a $202.18 consensus target.
SN presents a compelling growth story with strong profitability and product momentum, though elevated P/E of 38.5 suggests premium valuation. Key risks include consumer spending sensitivity and competitive pressures in home appliances. The stock's proximity to resistance at $192 requires monitoring for breakout confirmation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About SharkNinja Inc. Ordinary Shares
SharkNinja designs and sells small household appliances under the Shark and Ninja brands. Its products include cleaning appliances, kitchen and beverage appliances, food preparation products, and beauty and home-environment devices.
Read more on SN →
